Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BYM338 for Cachexia in Lung or Pancreatic Cancer
NCT01433263Phase 2Completed
- Sponsor
- Novartis
- Start
- Aug 2011
- Primary completion
- Apr 2014
- Modality
- Monoclonal Antibodies
- Countries
- 5
01
Overview
A Phase 2 trial of bimagrumab in cachexia, sponsored by Novartis. Started Aug 2011; status: completed.
02
Drugs
bimagrumab
03
Conditions
cachexia
Beyond the preview
Go deeper on NCT01433263.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01433263.